BioPortfolio.com — the life science, pharmaceutical and healthcare portal
Breaking News at 06:00 EST 27th January 2015
- 06:00 Spectro Scientific Strengthens Its Fluid Analysis Leadership Role with Acquisition of On-Site Analysis, Inc.
- 05:48 People evaluated for chest pain in emergency departments have low future risk of myocardial infarction, study finds
- 05:48 George John Cecil Brittain
- 05:48 Are soaring US malpractice rates just a memory now?
- 05:45 Cantargia Share Offering Prior to Planned Nasdaq First North Listing
- 05:40 Recommendation by the Nomination Committee concerning Board of Directors to be elected by the 2015 AGM of Orion Corporation
- 05:29 UPDATE 2-Siemens profit falls as price pressures hurt power and gas
- 05:20 Kidney cancer: Molecular subtype predicts sunitinib response in m-ccRCC
- 05:20 Prostate cancer: BAT-ting CRPC
- 05:15 Thinking bedside at the bench: the NOD mouse model of T1DM
- 05:15 Obesity: A new paradigm for treating obesity and diabetes mellitus
- 05:15 Obesity: Gut-specific FXR agonism
- 05:14 FDA approves Teva's version of AstraZeneca heartburn drug
- 05:10 UPDATE 2-Philips lags behind its profit targets as earnings slide
- 05:05 Ranbaxy fights on as Teva's generic Nexium hits US
- 05:03 Max India to be split into three separate companies
- 05:03 Positive Twelve-Month Tack Optimized Balloon Angioplasty (TOBA) Results Presented at LINC 2015
- 05:00 ‘Orthopedic Capital Of The World’ Is Still Hiring Despite Health Law Tax
- 05:00 Do I Have To Repay Premium Tax Credits If The Marketplace Miscalculated Them?
- 05:00 Learning About Hospice Should Begin Long Before You Are Sick
- 05:00 Mobile Application Pacifica Puts Powerful Therapy Tools into the Hands of Consumers
- 05:00 PolyScience Achieves ISO 14001:2004 Certification
- 05:00 Medical Guardian CEO Named in Smart CEO Magazine's Future 50
- 05:00 KCR Launches Innovative CTMS Platform in Cooperation with Quadratek
- 04:57 Novartis earnings fall as group sets up for future growth
Latest BioPortfolio blog: Medtronic in $43bn acquisition of Covidien - comment from Healthcare Analyst at The Economist Intelligence Unit
"Given the hostile reaction on both sides of the Atlantic to Pfizer's proposed tax inversion deal with AstraZeneca, it is no wonder that Medtronic is playing down the tax benefits of its deal with Covidien. Instead it is predicting innovation be... — Read more
- Screening Evaluation for Studies of the National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)
- Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)
- Novel Diagnostics With Optical Coherence Tomography: Imaging the Anterior Eye
- Ezetimibe Added to Statin Therapy (EASY) Study (0653-087)(COMPLETED)
- Different Ways to On-Line Hyphenate Centrifugal Partition Chromatography and Mass Spectrometry: Application to Prenylated Xanthones from Garcinia mangostana.
- Prediction of Anti-inflammatory Plants and Discovery of Their Biomarkers by Machine Learning Algorithms and Metabolomic Studies.
- Effects of Diene Valepotriates from Valeriana glechomifolia on Na+/K+-ATPase Activity in the Cortex and Hippocampus of Mice.
- Subtle skin involvement in nodal γδ peripheral T-cell lymphoma.
- Developing a Mobile Electronic D2B Checklist for Treatment of ST Elevation Myocardial Infarction Patients Who Need a Primary Coronary Intervention.